Back to AQR Capital Management LLC AQR Capital Management LLC

CORTCORT

Showing 8 of 31 quarters

Position history for AQR Capital Management LLCAQR Capital Management LLC's holdings in Corcept Therapeutics Incorporated

Yes. AQR Capital Management holds 2,582,561 shares of CORT (Corcept Therapeutics), worth $224.6M, as of its Q2 2026 13F filing. It increased the position from 406,205 shares in Q1 2026. AQR Capital Management has held CORT in every 13F on record since Q4 2018, 31 quarterly filings. CORT is 0.1% of AQR Capital Management's reported 13F portfolio.

Current Value

$224.6M

Current Shares

2.6M

Total Value Change

+$209.9M

Total Shares Change

+2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.6M
+535.8%
$224.6M0.1%$86.95
49
2026-Q1
Decreased
406,205
-54.3%
$15.9M0.0%$40.31
0
2025-Q4
Decreased
887,861
-41.1%
$30.9M0.0%$34.80
0
2025-Q3
Increased
1.5M
+546.9%
$125.3M0.1%$83.11
49
2025-Q2
Decreased
232,994
-7.9%
$17.1M0.0%$73.40
0
2025-Q1
Decreased
253,030
-8.5%
$28.9M0.0%$114.22
0
2024-Q4
Decreased
276,591
-12.5%
$13.9M0.0%$50.39
0
2024-Q3
Increased
315,955
+32.2%
$14.6M0.0%$46.28
36

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used